{"id":2,"date":"2024-02-16T17:22:54","date_gmt":"2024-02-16T17:22:54","guid":{"rendered":"https:\/\/bivacor.com\/?page_id=2"},"modified":"2024-04-20T13:56:46","modified_gmt":"2024-04-20T20:56:46","slug":"home","status":"publish","type":"page","link":"https:\/\/bivacor.com\/","title":{"rendered":"Home"},"content":{"rendered":"

BiVACOR\u00ae<\/b><\/span> Receives $13 Million to Support Clinical Trials for the Company\u2019s Total Artificial Heart<\/b><\/a>.<\/b><\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div>

Replacing Hearts.<\/h1><\/div>

Restoring Lives.<\/h1><\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div>

HEART FAILURE<\/h2><\/div>
<\/div><\/i><\/span>
<\/div><\/div>

Heart Failure (HF) is a devastating disease that affects more than 11 million people in the US and Europe, with an incidence of 1.1 million new cases per year. Furthermore, current growth rates predict a 25% increase in the incidence of HF by 2030.<\/p>\n

According to the US National Institutes of Health (NIH), 100,000 patients could immediately benefit from a ventricular assist device (VAD) or total artificial heart (TAH), and the European market is similarly sized. Without intervention, patients with severe HF have a bleak outlook. For these patients, drug therapy is a limited, relatively ineffective option. Although a heart transplant would meet their needs, only 4000 donor hearts are available globally each year.<\/p>\n<\/div>

Total Artificial Heart Therapy<\/h3><\/div>

Implantation of a TAH is a treatment option for patients with end-stage HF who need support while on a heart transplant waiting list or who do not qualify for a transplant. Removal of the native ventricles allows the device to completely replace the function of the native heart.<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>

DEVICE<\/h2><\/div>
<\/div><\/i><\/span>
<\/div><\/div>

The BiVACOR Total Artificial Heart (TAH) is designed to take over the complete function of a patient\u2019s failing heart.<\/p>\n<\/div><\/div><\/div>

<\/span><\/div><\/div><\/div>

Powerful<\/h4><\/div>

The centrifugal pumps can provide high flows over 12 L\/min for dynamic activity.<\/p>\n<\/div>

Smart<\/h4><\/div>

Smart controllers adapt the pump operation to changes in the patient\u2019s activity.<\/p>\n<\/div>

Durable<\/h4><\/div>

An anticipated device life of up to 10 years or more.<\/p>\n<\/div>

Small<\/h4><\/div>

Small enough for a child, powerful enough for an adult.<\/p>\n<\/div>

Portable<\/h4><\/div>

A small external controller and batteries to give patients freedom.<\/p>\n<\/div><\/div><\/div><\/div><\/div>

<\/div>
<\/div><\/div><\/div><\/div>
<\/div><\/div><\/div>

TECHNOLOGY<\/h2><\/div>
<\/div><\/i><\/span>
<\/div><\/div><\/div><\/div>

A Single Moving Part<\/h4><\/div>

Two centrifugal impellers placed on a single rotor provide perfusion to the left and right sides of the body.<\/p>\n<\/div><\/div><\/div>

Advantages of a Rotary Pump<\/h4><\/div>

Specially designed pump blades allow high flows and low power consumption.<\/p>\n<\/div><\/div><\/div>

Physiologic Interaction<\/h4><\/div>

The device\u2019s patented left-right flow-balancing system allows dynamic adaptation to change in the patient\u2019s physiology.<\/p>\n<\/div><\/div><\/div>

Active Magnetic Levitation<\/h4><\/div>

Magnetic levitation provides precise, stable operation with no mechanical wear.<\/p>\n<\/div><\/div><\/div>

Blood Compatibility<\/h4><\/div>

Special large gaps within the pump reduce blood cell damage and the risk of clotting.<\/p>\n<\/div><\/div><\/div>